Ulrike Eismann

486 total citations
16 papers, 355 citations indexed

About

Ulrike Eismann is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulrike Eismann has authored 16 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulrike Eismann's work include Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Ulrike Eismann is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Ulrike Eismann collaborates with scholars based in Germany, United States and United Kingdom. Ulrike Eismann's co-authors include Joachim Stoeber, Olaf Oberschmidt, Hartmut M. Hanauske‐Abel, Axel-Rainer Hanauske, Günter Stein, Reinhold Deppisch, Manfred Sommer, Heike Pospisil, Doreen Ma and Victor Chen and has published in prestigious journals such as Journal of Clinical Oncology, Kidney International and Personality and Individual Differences.

In The Last Decade

Ulrike Eismann

16 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Eismann Germany 10 102 97 87 81 58 16 355
Johannes Huesing Germany 9 98 1.0× 50 0.5× 203 2.3× 122 1.5× 69 1.2× 12 584
Sherry Owens United States 12 148 1.5× 52 0.5× 51 0.6× 141 1.7× 21 0.4× 33 544
Christina Theodore‐Oklota United States 10 37 0.4× 80 0.8× 56 0.6× 106 1.3× 18 0.3× 19 433
Andrea P. Malizia Italy 12 124 1.2× 58 0.6× 59 0.7× 46 0.6× 26 0.4× 24 500
Yvette Zimmerman Netherlands 15 86 0.8× 38 0.4× 21 0.2× 55 0.7× 36 0.6× 30 754
Fuquan Liu China 13 61 0.6× 67 0.7× 69 0.8× 98 1.2× 13 0.2× 31 513
Carla Pisani Italy 11 33 0.3× 76 0.8× 9 0.1× 45 0.6× 52 0.9× 35 414
David A. Kantorowitz United States 10 15 0.1× 43 0.4× 47 0.5× 86 1.1× 31 0.5× 18 400
Michael G. McCusker United States 10 109 1.1× 200 2.1× 88 1.0× 239 3.0× 28 0.5× 20 553
Ruiqi Chen China 11 186 1.8× 25 0.3× 116 1.3× 25 0.3× 44 0.8× 27 459

Countries citing papers authored by Ulrike Eismann

Since Specialization
Citations

This map shows the geographic impact of Ulrike Eismann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Eismann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Eismann more than expected).

Fields of papers citing papers by Ulrike Eismann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Eismann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Eismann. The network helps show where Ulrike Eismann may publish in the future.

Co-authorship network of co-authors of Ulrike Eismann

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Eismann. A scholar is included among the top collaborators of Ulrike Eismann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Eismann. Ulrike Eismann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hanauske, Axel-Rainer, Olaf Oberschmidt, Hartmut M. Hanauske‐Abel, Michael Lahn, & Ulrike Eismann. (2007). Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments. Investigational New Drugs. 25(3). 205–210. 30 indexed citations
2.
Hanauske, Axel-Rainer, Ulrike Eismann, Olaf Oberschmidt, et al.. (2007). Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells. Investigational New Drugs. 26(3). 215–222. 3 indexed citations
3.
Hanauske, Axel-Rainer, Ulrike Eismann, Olaf Oberschmidt, et al.. (2007). In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression. Investigational New Drugs. 25(5). 417–423. 74 indexed citations
4.
5.
Stoeber, Joachim & Ulrike Eismann. (2007). Perfectionism in young musicians: Relations with motivation, effort, achievement, and distress. Personality and Individual Differences. 43(8). 2182–2192. 131 indexed citations
6.
Eismann, Ulrike, et al.. (2006). Thymidylate synthase gene expression in solid tumors predicts for response to pemetrexed in vitro. Journal of Clinical Oncology. 24(18_suppl). 13058–13058. 7 indexed citations
7.
Oberschmidt, Olaf, Ulrike Eismann, Michael Lahn, et al.. (2006). In vitro chemosensitivity against enzastaurin correlates with gene expression of IL8 and GSK3-beta. Journal of Clinical Oncology. 24(18_suppl). 13046–13046. 1 indexed citations
8.
Eismann, Ulrike, et al.. (2005). Pemetrexed: mRNA expression of the target genes TS, GARFT and DHFR correlates with the in vitro chemosensitivity of human solid tumors. International Journal of Clinical Pharmacology and Therapeutics. 43(12). 567–569. 9 indexed citations
9.
Oberschmidt, Olaf, et al.. (2005). Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro.. PubMed. 43(12). 603–4. 15 indexed citations
10.
Oberschmidt, Olaf, Ulrike Eismann, J. Blatter, et al.. (2004). Pemetrexed: Target gene expression in human solid tumors correlates with chemosensitivity patterns. Journal of Clinical Oncology. 22(14_suppl). 3128–3128. 1 indexed citations
11.
Sommer, Manfred, Ulrike Eismann, Jens Gerth, & G Stein. (2002). Interleukin 4 Co-Stimulates the PDGF-BB- and bFGF-Mediated Proliferation of Mesangial Cells and Myofibroblasts. ˜The œNephron journals/Nephron journals. 92(4). 868–882. 12 indexed citations
12.
Eismann, Ulrike, Manfred Sommer, Hartwig Kosmehl, et al.. (2002). Fibronectin Splice Variants – Prognostic Markers for the Stage of Renal Interstitial Fibrosis in the Rat. ˜The œNephron journals/Nephron journals. 92(2). 379–388. 11 indexed citations
13.
Eismann, Ulrike, et al.. (2001). Expression of β2-microglobulin and c-fos mRNA: Is there an influence of high- or low-flux dialyzer membranes?. Kidney International. 59. S177–S181. 12 indexed citations
14.
Eismann, Ulrike, et al.. (2001). Expression of beta2-microglobulin and c-fos mRNA: Is there an influence of high- or low-flux dialyzer membranes?. Kidney International. 59(s78). 177–181. 1 indexed citations
15.
Eismann, Ulrike, et al.. (2001). Expression of beta2-microglobulin and c-fos mRNA: Is there an influence of high- or low-flux dialyzer membranes?. Kidney International. 59(s78). 177–181. 8 indexed citations
16.
Sommer, Manfred, Ulrike Eismann, Winnie Deuther‐Conrad, et al.. (2000). Time Course of Cytokine mRNA Expression in Kidneys of Rats with Unilateral Ureteral Obstruction. ˜The œNephron journals/Nephron journals. 84(1). 49–57. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Huesing Breakdown of academic impact, for papers by Sherry Owens Breakdown of academic impact, for papers by Christina Theodore‐Oklota Breakdown of academic impact, for papers by Andrea P. Malizia Breakdown of academic impact, for papers by Yvette Zimmerman Breakdown of academic impact, for papers by Fuquan Liu Breakdown of academic impact, for papers by Carla Pisani Breakdown of academic impact, for papers by David A. Kantorowitz Breakdown of academic impact, for papers by Michael G. McCusker Breakdown of academic impact, for papers by Ruiqi Chen
Rankless by CCL
2026